Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8455846 | 0.96 | ALDH1A1 (0.80) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL6687414 | 0.94 | ALDH1A1 (0.88) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL14065851 | 0.91 | ALDH1A1 (0.88) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL17559526 | 0.91 | ALDH1A1 (0.88) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL18863120 | 0.91 | ALDH1A1 (0.77) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL12977820 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL12977802 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL12977814 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL38306 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL12977818 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103087576-A | Surfactant Composition, Coating Solution Containing The Surfactant Composition, And Rubber Article Treated By The Coating Solution | SHINETSU CHEMICAL CO | 2013-05-08 | — | — | CN | disclosed |
| US-20030158448-A1 | Glycidyl ether-capped acetylenic diol ethoxylate surfactants | EVONIK DEGUSSA GMBH (DE) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158448-A1 | Glycidyl ether-capped acetylenic diol ethoxylate surfactants | AGL, ALK, ALG1 | ALDH1A1 1912/4885TDP1 4291/4885SMN1; SMN2 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.